- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03970525
Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery
A Comparison of Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is an open, prospective, randomized study to evaluate efficiency and outcomes of femtosecond laser cataract surgery with phacoemulsification performed with one of two standard vacuum systems.
It is estimated that the duration of study participation will be up to 24 months.
There will be randomization to 1 of 2 groups. Both eyes of each subject will be enrolled in the study. The first eye will be randomized to either the Venturi or peristaltic-based vacuum pump. The second eye will then receive the other type of vacuum pump for that procedure.
Study Phases:
Pre-operative Visit Procedure Post-operative Follow up The subject will be seen 1 day, 5-10 days, and 90 days following the procedure.
Surgical Procedure
- The cataract removal procedure will be performed under sterile technique and according to standard procedures. The femtosecond laser treatment will be followed by phacoemulsification removal of the cataract and implantation of an intraocular lens.
- Peri-operatively, subjects will be treated with a regimen of antibiotic, steroid and nonsteroidal anti-inflammatory eye drops per standard of care.
- All surgeries will be performed by the same experienced surgeon/principal investigator using the Catalys® SYSTEM femtosecond laser platform and WHITESTAR SIGNATURE® PRO Phacoemulsification System.
Phacoemulsification Settings:
- For Venturi pump: 600 mmHg vacuum
- For Peristaltic-based pump: 600 mmHg vacuum and aspiration flow of 50 mL/min
- Other settings: ultrasound energy application parameters will be the same for the two groups
Study Procedures
- The study will include routine cataract pre-operative testing with Nidek OPD, Galilei G4, and IOLMaster, and repeated at the post-op visits. An endothelial cell count of the cornea will be performed at the pre-operative visit and at the 90 day follow up visit.
- Subjects will be randomized to phacoemulsification settings of Venturi vacuum of 600 mmHg or peristaltic vacuum of 600 mmHg and aspiration flow of 50 mL/min. All other phacoemulsification settings will be identical. The laser settings will be based on the grade of cataract only and will not be altered for this study.
- The phacoemulsification time, energy Ellips FX EFX, and average phacoemulsification energy will be recorded. The laser procedure time and total procedure time will be recorded. Complications will be recorded. Additional patient characteristics will also be recorded.
Pre-Operative Visit:
- Nidek Refractive Power/Corneal Analyzer OPD-Scan, Galilei G4 Corneal Topography, IOLMaster 700 keratometry (standard of care)
- Complete eye examination (standard of care)
- Brightness Acuity Test (BAT) (standard of care)
- Review and confirm eligibility (research)
- Informed Consent for study (research)
- Randomization (research)
- Endothelial Cell Count (research)
- Medical Record Review (research)
Surgical Procedure (Day 0) (standard of care)
- Medical Record Review (research)
- Adverse Event Assessment (research)
Post-operative Visit 1 (Day 1):
- Eye exam to include uncorrected and pinhole visual acuity, Intraocular pressure (IOP) and slit-lamp exam (standard of care)
- Galilei G4 Corneal Topography, IOLMaster 700 keratometry (standard of care)
- Medical Record Review (research)
- Adverse Event Assessment (research)
Post-operative Visit 2 (Day 5-10):
- Eye exam to include uncorrected and best corrected visual acuity, Pinhole visual acuity, IOP, and slit-lamp exam (standard of care)
- Nidek Refractive Power/Corneal Analyzer OPD-Scan, Galilei G4 Corneal Topography, IOLMaster 700 keratometry (standard of care)
- Medical Record Review (research)
- Adverse Event Assessment (research)
Post-operative Visit 3 (Day 60-90 days):
- Eye exam to include uncorrected and best corrected visual acuity, Pinhole visual acuity, IOP, and slit-lamp exam (research)
- Nidek Refractive Power/Corneal Analyzer OPD-Scan, Galilei G4 Corneal Topography, IOLMaster 700 keratometry (research)
- Endothelial Cell Count (research)
- Medical Record Review (research)
- Adverse Event Assessment (research)
Unscheduled Visit:
- A medical record review and an adverse event assessment will be performed at any unscheduled visit.
- Additional evaluations will be completed at the discretion of the Principal Investigator based on the subject's presenting complaint.
Statistical Analysis
Sample Size and Power:
· The study aims to enroll 250 study subjects for a total of 500 eyes with bilateral grade 1-3 nuclear sclerotic cataracts who will be undergoing planned femtosecond laser cataract surgery.
Statistical Methods:
· The statistical analysis plan will include use of descriptive statistics and statistical tests including unpaired t-tests.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Missouri
-
Springfield, Missouri, United States, 65804
- Mercy Clinic Eye Specialists
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- The study aims to enroll 250 study subjects for a total of 500 eyes with bilateral grade 1-3 nuclear sclerotic cataracts who will be undergoing planned femtosecond laser cataract surgery.
- The study will include adults undergoing femtosecond laser cataract surgery with grade 1-3 nuclear sclerotic cataracts.
Description
Inclusion Criteria:
- Males and females ages 22-90 yrs
- Diagnosis of senile cataract
- Grade 1-3 Nuclear sclerosis
- Cataract removal required for both eyes
- Scheduled for femtosecond laser cataract surgery at Mercy Surgery Center or Mercy National Eye Center in Springfield, MO
Exclusion Criteria:
- Diagnosis of Fuch's dystrophy
- Presence of cornea scars
- Planned laser astigmatism treatment
- Diagnosis of pseudoexfoliation
- History of direct ocular trauma with secondary iris or lens trauma
- Presence of grade 4 cataracts
- History of previous eye surgery
- Severe glaucoma or retina disease impairing vision
- Planned surgery that is will be combined with other surgical eye procedures
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Venturi pump
This cohort will receive femtosecond laser cataract surgery with Venturi pump.
|
The venturi pump makes use of the venturi effect to create a vacuum.
The venturi effect creates a vacuum by the flow of a fluid, typically air, over an opening.
In many phacoemulsification machines, this requires nitrogen tanks or a self-contained air compressor.
The vacuum level is created within a rigid drainage cassette, to which the phaco aspiration tubing is connected.
Since there is no milking of the aspiration line, the phaco tubing can be made rigid with low compliance.
|
|
Peristaltic vacuum pump
This cohort will receive femtosecond laser cataract surgery with peristaltic pump.
|
The peristaltic pump uses rollers to compress the phacoemulsification outflow tubing in a peristaltic manner, thereby creating flow and vacuum.
The compression of the rollers on the tubing with the rotation of the pump physically moves fluid and creates a continuous "milking" action on the fluid column, The phaco machine can directly control this flow level, hence the term flow based, however, the preset vacuum level is only achieved once there is occlusion of the outflow line, typically at the phaco needle tip with cataract material.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Phacoemulsification energy required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
|
Phaco EFX (the effective phaco time with a specific coefficient for the transversal movement of the phaco tip- expressed in seconds.)
|
Intraoperative Visit
|
|
Duration of ultrasound time required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
|
Total ultrasound time - measured in seconds
|
Intraoperative Visit
|
|
Phacoemulsification power required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
|
Average power - measured in percentage
|
Intraoperative Visit
|
|
Duration of microscope time required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
|
Microscope time - measured in seconds intraoperatively
|
Intraoperative Visit
|
|
Duration of laser time required during femtosecond laser cataract surgery procedure
Time Frame: Intraoperative Visit
|
Laser time - measured in seconds intraoperatively
|
Intraoperative Visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uncorrected visual acuity among subjects who underwent femtosecond laser cataract surgery procedure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
1) Uncorrected Visual Acuity using the Snellen Eye Chart
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
|
Best Corrected Visual Acuity among subjects who underwent femtosecond laser cataract surgery procedure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
Best Corrected Visual Acuity using the Snellen Eye Chart
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
|
Pinhole Visual Acuity among subjects who underwent femtosecond laser cataract surgery procedure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
Pinhole visual acuity using pinhole technique and the Snellen eye chart
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
|
Presence of corneal edema as assessed by intra-ocular pressure
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
Measured in mmHg using an applanation tonometer
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
|
Presence of corneal edema as assessed by slit lamp examination
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
The examiner will use a slit lamp microscope to evaluate the eye structures and intra-ocular pressure
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
|
Measure of the corneal endothelium
Time Frame: This test will be done Pre-operatively and Post op 60-90 day visit
|
Endothelial Cell Count will be evaluated by Konan Specular Microscopy
|
This test will be done Pre-operatively and Post op 60-90 day visit
|
|
Central corneal thickness as measured by IOLMaster Biometry
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
IOL Master Biometry directly measures the corneal thickness by OCT
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
|
Central corneal thickness as measured by Galilei G4 Biometry
Time Frame: This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
Galilei G4 measures central corneal thickness
|
This test will be done Pre-operatively and at Post op day 1, Post op day 5-10, and Post op day 60-90
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse Events
Time Frame: 90 days
|
Adverse Events will be recorded an monitored for each group and compared.
|
90 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wendell J Scott, MD, Mercy Hospital
Publications and helpful links
General Publications
- Wang J, Zhao J, Xu J, Zhang J. Evaluation of the effectiveness of combined femtosecond laser-assisted cataract surgery and femtosecond laser astigmatic keratotomy in improving post-operative visual outcomes. BMC Ophthalmol. 2018 Jul 3;18(1):161. doi: 10.1186/s12886-018-0823-1.
- Day AC, Smith PR, Tang HL, Aiello F, Hussain B, Maurino V, Marshall J, Saleh GM. Surgical efficiency in femtosecond laser cataract surgery compared with phacoemulsification cataract surgery: a case-control study. BMJ Open. 2018 Feb 17;8(2):e018478. doi: 10.1136/bmjopen-2017-018478.
- Basic Principles of Phacoemulsification and Fluid Dynamics. Retrieved from https://www.aao.org/focalpointssnippetdetail.aspx?id=fde87039-2700-4d45-808a-9af6226a983d
- 5. Peristaltic and Venturi Fluid Pumps. Retrieved from https://www.aao.org/focalpointssnippetdetail.aspx?id=42e35231-7641-4190-b0cd-7ffdc1b8de74
- DeMill DL, Zaugg BE, Pettey JH, Jensen JD, Jardine GJ, Wong G, Olson RJ. Objective comparison of 4 nonlongitudinal ultrasound modalities regarding efficiency and chatter. J Cataract Refract Surg. 2012 Jun;38(6):1065-71. doi: 10.1016/j.jcrs.2011.12.040.
- Conrad-Hengerer I, Hengerer FH, Schultz T, Dick HB. Effect of femtosecond laser fragmentation on effective phacoemulsification time in cataract surgery. J Refract Surg. 2012 Dec;28(12):879-83. doi: 10.3928/1081597X-20121116-02.
- 1. Jacobs, DS. (2019). Cataract in Adults. In T.W. Post, J. Trobe & J. Givens (Eds.), UpToDate. Available from https://www.uptodate.com/contents/cataract-in-adults?search=cataract&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract Senile
-
Carl Zeiss Meditec AGCompleted
-
Carl Zeiss Meditec AGRecruitingCataract SenileSpain, Bulgaria, Czechia, Romania
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityBeijing Tongren Hospital; Eye & ENT Hospital of Fudan University; The First Affiliated... and other collaboratorsEnrolling by invitation
-
Taipei Nobel Eye ClinicCompletedCataract SenileTaiwan
-
Carl Zeiss Meditec AGCompletedCataract SenileRomania
-
Carl Zeiss Meditec AGCompleted
-
Johannes Kepler University of LinzCompleted
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
Qinghai UniversityUnknown
Clinical Trials on Venturi pump
-
Instituto Nacional de Ciencias Medicas y Nutricion...Completed
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
University Health Network, TorontoUnknown
-
Catholic University of the Sacred HeartCompletedRespiratory FailureItaly
-
University of Campania "Luigi Vanvitelli"CompletedObesity | Postoperative Respiratory DistressItaly
-
University of Sao PauloTerminated
-
Hospital Italiano de Buenos AiresUnknown
-
Hospital Italiano de Buenos AiresCompleted
-
ASST Fatebenefratelli SaccoCompletedContinuous Positive Airway Pressure [E02.041.625.790.259] | Prostatectomy [E04.950.774.860.625] | Laparoscopy [E01.370.388.250.520] | Pneumoperitoneum [C06.844.670]Italy